an in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power.
Nonclinical
Chemical
Analysis
Johne (2023)
Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects of metformin using small-molecular-weight paracellular markers.
Nonclinical
Immunotoxicity
In Vitro
Kadry (2021)
Investigating DNa adduct formation by flavor chemicals and tobacco byproducts in electronic nicotine delivery system (ENDS) using in silico approaches.
Nonclinical
Genotoxicity
In Vitro
Kang (2020)
alterations of Mitochondrial Network by Cigarette Smoking and E-Cigarette Vaping.
Nonclinical
Genotoxicity
In Vitro
Kanithi (2022)
Metabolites of Tobacco- and E-Cigarette-Related Nitrosamines Can Drive Cu2+-Mediated DNa Oxidation.
Nonclinical
Genotoxicity
In Vitro
Kankanamage (2020)
Examining Metal Contents in Primary and Secondhand aerosols Released by Electronic Cigarettes.
Nonclinical
Chemical
Analysis
Kapiamba (2022)
Differential plasma exosomal long non-coding RNas expression profiles and their emerging role in E-cigarette users, cigarette, waterpipe, and dual smokers.
Nonclinical
Genotoxicity
In Vivo
Kaur (2020)
Expression of Key Inflammatory Proteins Is Increased in Immune Cells From Tobacco Cigarette Smokers But Not Electronic Cigarette Vapers: Implications for atherosclerosis.
Nonclinical
Immunotoxicity
In Vivo
Kelesidis (2021)
Increased Expression of Proatherogenic Proteins in Immune Cell Subtypes in Tobacco Cigarette Smokers But Not in Electronic Cigarette Vapers.
Nonclinical
Immunotoxicity
In Vivo
Kelesidis (2021)
Nicotine Exposure Via Electronic Cigarettes Significantly Impedes Biomechanical healing Properties of Tendon healing in a Rat Model.
Nonclinical
Safety Effects In Animals
Repeat-dose
Kennedy (2021)